
|Articles|October 7, 2015
Worldwide Medtech Sales Forecast to Reach $477.5 Billion by 2020
October 07, 2015.
Advertisement
The value of the global medtech market is expected to reach $477.5 billion by 2020, according life sciences market intelligence firm Evaluate Ltd. The “EvaluateMedTech World Preview 2015, Outlook to 2020” also states that worldwide medtech R&D expenditure is forecast to grow by 3.5 percent per annum to reach $29.5 billion by 2020. Other findings from the 2015 report:
- Worldwide medtech market forecast to grow more slowly than prescription drug market, with a CAGR of 4.1 percent between 2014 and 2020 versus 4.9 percent for pharma.
- Total medtech M&A deal values rose 166 percent to $84 billion in H1 2015.
- Medtronic’s $49.9 billion acquisition of Covidien in January 2015 was the biggest deal in medtech history.
- Johnson & Johnson held on to number one position in 2014 with medtech sales of $27.5 billion but Medtronic steals the top spot from 2015 onwards with a 2020 sales forecast of $34.9 billion.
The report can be downloaded at
http://www.evaluategroup.com/MedtechWP2015
.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
2
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
3
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
4
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
5




